Cusatuzumab, AZACITIDINE, AZACITIDINE clinical trials

A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia who are not Candidates for Intensive Chemotherapy

This study is looking at a new combination treatment for acute myeloid leukaemia (AML) in people who can't have strong chemotherapy. It combines two drugs, cusatuzumab and azacitidine, to see how well they help improve the patient's condition.